• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电喷雾柚皮苷载药微球/SAIB 混合微球库增强了小鼠颅骨缺损模型中的骨形成。

Electrosprayed naringin-loaded microsphere/SAIB hybrid depots enhance bone formation in a mouse calvarial defect model.

机构信息

a Department of Prosthodontics , Stomatological Hospital of Chongqing Medical University , Chongqing , China.

b Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences , Chongqing , China.

出版信息

Drug Deliv. 2019 Dec;26(1):137-146. doi: 10.1080/10717544.2019.1568620.

DOI:10.1080/10717544.2019.1568620
PMID:30799644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6394313/
Abstract

The burst release of active osteogenic factors, which is not beneficial to osteogenesis, is commonly encountered in bone tissue engineering. The aims of this study were to prepare naringin-loaded microsphere/sucrose acetate isobutyrate (Ng-m-SAIB) hybrid depots, reduce the burst release of naringin (Ng), and improve osteogenesis. The morphology and size distributions of electrosprayed Ng-microspheres were characterized by scanning electron microscopy (SEM). The Ng-microspheres and Ng-m-SAIB depots were characterized by Fourier transform infrared spectroscopy (FTIR) and in vitro release studies. In vitro osteoblast-microsphere interactions and in vivo osteogenesis were assessed after implantation of Ng-m-SAIB depots. The addition of sucrose acetate isobutyrate (SAIB) to monodisperse Ng-microspheres did not cause a change in the chemical structure. The performances of the microspheres in osteoblast-microsphere interactions were better when the naringin content was 4% than when it was at 2% and 6%. On the first day following the loading of Ng-microspheres (2%, 4%, and 6%) into SAIB depots, the burst release was reduced dramatically from 70.9% to 6.3%, 73.1% to 7.2%, and 73.9% to 9.9%, respectively. In addition, after 8 weeks, the new bone formation rate in the calvarial defects of SD rats receiving Ng-m-SAIB was 53.1% compared to 21.2% for the control group and 16.1% for the microsphere-SAIB group. These results demonstrated that Ng-m-SAIB hybrid depots may have promise in bone regeneration applications.

摘要

在骨组织工程中,经常会遇到活性成骨因子的爆发释放,这不利于成骨。本研究旨在制备柚皮苷载药微球/醋酸丁酸蔗糖酯(Ng-m-SAIB)混合储库,减少柚皮苷(Ng)的爆发释放,并改善成骨作用。通过扫描电子显微镜(SEM)对电纺 Ng 微球的形态和粒径分布进行了表征。通过傅里叶变换红外光谱(FTIR)和体外释放研究对 Ng 微球和 Ng-m-SAIB 储库进行了表征。植入 Ng-m-SAIB 储库后,评估了 Ng-m-SAIB 储库对成骨细胞-微球相互作用和体内成骨的影响。在单分散 Ng 微球中添加醋酸丁酸蔗糖酯(SAIB)不会引起化学结构的变化。当柚皮苷含量为 4%时,微球在成骨细胞-微球相互作用中的性能优于 2%和 6%。在将 Ng 微球(2%、4%和 6%)载入 SAIB 储库的第一天,突释从 70.9%分别显著降低至 6.3%、73.1%至 7.2%和 73.9%至 9.9%。此外,在 8 周后,接受 Ng-m-SAIB 的 SD 大鼠颅骨缺损中的新骨形成率为 53.1%,而对照组为 21.2%,微球-SAIB 组为 16.1%。这些结果表明,Ng-m-SAIB 混合储库可能在骨再生应用中具有潜力。

相似文献

1
Electrosprayed naringin-loaded microsphere/SAIB hybrid depots enhance bone formation in a mouse calvarial defect model.电喷雾柚皮苷载药微球/SAIB 混合微球库增强了小鼠颅骨缺损模型中的骨形成。
Drug Deliv. 2019 Dec;26(1):137-146. doi: 10.1080/10717544.2019.1568620.
2
Controlled released naringin-loaded liposome/sucrose acetate isobutyrate hybrid depot for osteogenesis and .用于成骨的控释载柚皮苷脂质体/蔗糖乙酸异丁酸酯混合长效注射剂
Front Bioeng Biotechnol. 2023 Jan 5;10:1097178. doi: 10.3389/fbioe.2022.1097178. eCollection 2022.
3
Electrosprayed minocycline hydrochloride-loaded microsphere/SAIB hybrid depot for periodontitis treatment.电喷雾盐酸米诺环素载药微球/SAIB 混合缓释剂治疗牙周炎。
Drug Deliv. 2021 Dec;28(1):620-633. doi: 10.1080/10717544.2021.1902020.
4
Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.追踪微球大小对微球/醋酸异丁酸蔗糖酯(SAIB)混合长效注射剂体外及体内药物释放的影响。
Drug Dev Ind Pharm. 2016 Sep;42(9):1455-65. doi: 10.3109/03639045.2016.1143952. Epub 2016 Feb 17.
5
[Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].[利培酮微球/醋酸蔗糖异丁酸酯原位形成具有双重扩散屏障的复合长效注射剂的制备与评价]
Yao Xue Xue Bao. 2015 Jun;50(6):775-82.
6
A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.一种具有低突释特性的均匀超小微球/SAIB混合长效制剂用于长期持续药物释放。
Pharm Res. 2015 Nov;32(11):3708-21. doi: 10.1007/s11095-015-1731-1. Epub 2015 Jun 16.
7
Electrospun naringin-loaded microsphere/sucrose acetate isobutyrate system promotes macrophage polarization toward M2 and facilitates osteoporotic bone defect repair.电纺载柚皮苷微球/醋酸异丁酸蔗糖酯体系促进巨噬细胞向M2极化并促进骨质疏松性骨缺损修复。
Regen Biomater. 2023 Feb 20;10:rbad006. doi: 10.1093/rb/rbad006. eCollection 2023.
8
Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots.原位形成的蔗糖醋酸异丁酸酯贮库包裹的葫芦素聚乳酸-乙醇酸共聚物微球瘤内给药抗肿瘤疗效的改善
J Pharm Sci. 2016 Jan;105(1):205-11. doi: 10.1002/jps.24695. Epub 2016 Jan 13.
9
In vitro study of lysozyme in poly(lactide-co-glycolide) microspheres with sucrose acetate isobutyrate.溶菌酶在含蔗糖乙酸异丁酸酯的聚(丙交酯-共-乙交酯)微球中的体外研究。
Eur J Pharm Sci. 2006 Dec;29(5):435-41. doi: 10.1016/j.ejps.2006.08.005. Epub 2006 Aug 18.
10
[Preparation of berberine-naringin dual drug-loaded composite microspheres and evaluation of their antibacterial-osteogenic properties].黄连素-柚皮苷双药负载复合微球的制备及其抗菌成骨性能评价
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 Dec 15;37(12):1505-1513. doi: 10.7507/1002-1892.202308054.

引用本文的文献

1
Dual delivery of metformin and Y15 from a PLGA scaffold for the treatment of platinum-resistant ovarian cancer.从聚乳酸-羟基乙酸共聚物(PLGA)支架中双重递送二甲双胍和Y15用于治疗铂耐药性卵巢癌。
Future Med Chem. 2025 Feb;17(3):301-312. doi: 10.1080/17568919.2025.2458457. Epub 2025 Jan 31.
2
Recent advancements in drug delivery system of flavonoids with a special emphasis on the flavanone naringenin: exploring their application in wound healing and associated processes.黄酮类化合物给药系统的最新进展,特别强调黄烷酮柚皮素:探索它们在伤口愈合及相关过程中的应用。
Inflammopharmacology. 2025 Jan;33(1):69-90. doi: 10.1007/s10787-024-01600-1. Epub 2024 Nov 22.
3

本文引用的文献

1
Naringin enhances osteogenic differentiation through the activation of ERK signaling in human bone marrow mesenchymal stem cells.柚皮苷通过激活人骨髓间充质干细胞中的ERK信号通路增强成骨分化。
Iran J Basic Med Sci. 2017 Apr;20(4):408-414. doi: 10.22038/IJBMS.2017.8582.
2
Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.鹿茸多肽通过调控核因子κB信号通路促进成骨细胞分化并抑制破骨细胞生成。
Biochem Biophys Res Commun. 2017 Sep 16;491(2):388-395. doi: 10.1016/j.bbrc.2017.07.091. Epub 2017 Jul 18.
3
Controlled Release of Naringin in Metal-Organic Framework-Loaded Mineralized Collagen Coating to Simultaneously Enhance Osseointegration and Antibacterial Activity.
Targeting micromotion for mimicking natural bone healing by using NIPAM/NbC hydrogel.
通过使用NIPAM/NbC水凝胶靶向微动以模拟自然骨愈合。
Bioact Mater. 2024 May 16;39:41-58. doi: 10.1016/j.bioactmat.2024.05.023. eCollection 2024 Sep.
4
Flavonoid-Loaded Biomaterials in Bone Defect Repair.载黄酮类化合物的生物材料在骨缺损修复中的应用。
Molecules. 2023 Sep 30;28(19):6888. doi: 10.3390/molecules28196888.
5
The application of electrosprayed minocycline-loaded PLGA microparticles for the treatment of glioblastoma.载米诺环素电喷 PLGA 微球在治疗脑胶质母细胞瘤中的应用。
Biotechnol Bioeng. 2023 Nov;120(11):3409-3422. doi: 10.1002/bit.28527. Epub 2023 Aug 22.
6
Bioactive Materials for Bone Regeneration: Biomolecules and Delivery Systems.用于骨再生的生物活性材料:生物分子和递送系统。
ACS Biomater Sci Eng. 2023 Sep 11;9(9):5222-5254. doi: 10.1021/acsbiomaterials.3c00609. Epub 2023 Aug 16.
7
Bisphosphonate-incorporated coatings for orthopedic implants functionalization.用于骨科植入物功能化的含双膦酸盐涂层
Mater Today Bio. 2023 Jul 22;22:100737. doi: 10.1016/j.mtbio.2023.100737. eCollection 2023 Oct.
8
The Development of Naringin for Use against Bone and Cartilage Disorders.柚皮苷在防治骨与软骨疾病中的应用进展。
Molecules. 2023 Apr 25;28(9):3716. doi: 10.3390/molecules28093716.
9
Naringin: Nanotechnological Strategies for Potential Pharmaceutical Applications.柚皮苷:潜在药物应用的纳米技术策略
Pharmaceutics. 2023 Mar 7;15(3):863. doi: 10.3390/pharmaceutics15030863.
10
Polymeric and Composite Carriers of Protein and Non-Protein Biomolecules for Application in Bone Tissue Engineering.用于骨组织工程的蛋白质和非蛋白质生物分子的聚合物及复合载体
Materials (Basel). 2023 Mar 10;16(6):2235. doi: 10.3390/ma16062235.
载药矿化胶原涂层中柚皮苷的控制释放以同时增强骨整合和抗菌活性
ACS Appl Mater Interfaces. 2017 Jun 14;9(23):19698-19705. doi: 10.1021/acsami.7b05296. Epub 2017 Jun 5.
4
Structural characterization and bioavailability of ternary nanoparticles consisting of amylose, α-linoleic acid and β-lactoglobulin complexed with naringin.由直链淀粉、α-亚油酸和与柚皮苷复合的β-乳球蛋白组成的三元纳米颗粒的结构表征及生物利用度
Int J Biol Macromol. 2017 Jun;99:365-374. doi: 10.1016/j.ijbiomac.2017.03.005. Epub 2017 Mar 2.
5
Design of novel injectable in-situ forming scaffolds for non-surgical treatment of periapical lesions: In-vitro and in-vivo evaluation.新型可注射原位形成支架治疗根尖周病变的设计:体外和体内评价。
Int J Pharm. 2017 Apr 15;521(1-2):306-317. doi: 10.1016/j.ijpharm.2017.02.058. Epub 2017 Feb 21.
6
Reloadable Silk-Hydrogel Hybrid Scaffolds for Sustained and Targeted Delivery of Molecules.用于分子持续靶向递送的可再装填丝-水凝胶混合支架
Mol Pharm. 2016 Dec 5;13(12):4066-4081. doi: 10.1021/acs.molpharmaceut.6b00672. Epub 2016 Nov 7.
7
Drug-nanoencapsulated PLGA microspheres prepared by emulsion electrospray with controlled release behavior.通过乳液电喷雾法制备的具有控释行为的药物纳米包封聚乳酸-羟基乙酸共聚物微球。
Regen Biomater. 2016 Oct;3(5):309-317. doi: 10.1093/rb/rbw033. Epub 2016 Sep 21.
8
Therapeutic potential of naringin: an overview.柚皮苷的治疗潜力:综述
Pharm Biol. 2016 Dec;54(12):3203-3210. doi: 10.1080/13880209.2016.1216131. Epub 2016 Aug 26.
9
Naringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone.柚皮苷可改善坐骨神经切断术诱导的骨质流失,并增加去神经支配骨中信号素3A的表达。
Sci Rep. 2016 Apr 25;6:24562. doi: 10.1038/srep24562.
10
The Function of Naringin in Inducing Secretion of Osteoprotegerin and Inhibiting Formation of Osteoclasts.柚皮苷在诱导骨保护素分泌及抑制破骨细胞形成中的作用
Evid Based Complement Alternat Med. 2016;2016:8981650. doi: 10.1155/2016/8981650. Epub 2016 Jan 14.